author-photo

Christina Krupka

Ludwig Maximilian University of Munich

37

Papers

882

Citations

Citation Trend

Filter By

Papers (23) Sort By

Journal Conference Others

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC specific T-cell bispecific antibody.

2021 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Characterization of a Novel FLT3 BiTE® Antibody Construct for the Treatment of Acute Myeloid Leukemia.

2020 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (9)
TARGETING FLT3 IN AML: MODULATION OF FLT3-BITE® ACTIVITY THROUGH COMBINATION WITH VARIOUS TKI: PF217

2019
Show All
- Source
- Cite
- Save
Citations (0)
Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells

2018 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (9)
Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

2018 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

2018 Blood
Show All
- Source
- Cite
- Save
Citations (36)
Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia

2018 Leukemia
Show All
- Source
- Cite
- Save
Citations (45)
Evaluation of a FLT3 Bite® for Acute Myeloid Leukemia

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Administration d'une construction bispécifique se liant à cd33 et cd3 destinée à une utilisation dans un procédé de traitement de la leucémie myéloïde

2017
Show All
- Source
- Cite
- Save
Citations (0)
Identification of Novel Targets for Antibody or Chimeric Antigen Receptor (CAR) Based Immunotherapy in AML: Characterizing the Surfaceome from Primary Patient Samples

2017 Blood
Show All
- Source
- Cite
- Save
Citations (1)